Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats

Abstract

Chronic opiates induce the development of physical dependence. Opioid physical dependence characterized by withdrawal symptoms, may have very long-lasting effects on the motivation for reward, including the incubation of cue-induced drug-seeking behavior. Elucidation of the mechanisms involved in physical dependence is crucial to developing more effective treatment strategies for opioid dependence. Chronic morphine induces production of proinflammatory cytokines in regional-specific sites of the brain. Interleukin-4 (IL-4) is a prototypical anti-inflammatory cytokine that globally suppresses proinflammatory cytokines. Here, we used recombinant herpes simplex virus vector S4IL4 that encode mouse il4 gene to evaluate the therapeutic potential of IL-4 in naloxone-precipitation morphine withdrawal (MW). One week after microinjection of the vector S4IL4 into the PAG LacZ or mouse IL-4 immunoreactivity in the vlPAG was visualized. ELISA assay showed that vector S4IL4 into the PAG induced the expression of IL-4. S4IL4 blunted the morphine withdrawal syndrome. S4IL4 suppressed the upregulated TNFα, NR2B and pC/EBPβ in the PAG induced by MW. These results show that inhibition of proinflammatory factor in the PAG suppressed MW. This study may provide a novel therapeutic approach to morphine physical withdrawal symptoms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Hasanein P, Teimuri Far M, Emamjomeh A . Salvia officinalis L. attenuates morphine analgesic tolerance and dependence in rats: possible analgesic and sedative mechanisms. Am J Drug Alcohol Abuse 2015; 41: 405–413.

    Article  PubMed  Google Scholar 

  2. Cooper ZD, Johnson KW, Pavlicova M, Glass A, Vosburg SK, Sullivan MA et al. The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addict Biol 2015; 21: 895–903.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Taylor DA, Fleming WW . Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 2001; 297: 11–18.

    CAS  PubMed  Google Scholar 

  4. Rouibi K, Contarino A . Increased motivation to eat in opiate-withdrawn mice. Psychopharmacology 2012; 221: 675–684.

    Article  CAS  PubMed  Google Scholar 

  5. Anderson EM, Neubert JK, Caudle RM . Long-term changes in reward-seeking following morphine withdrawal are associated with altered N-methyl-D-aspartate receptor 1 splice variants in the amygdala. Neuroscience 2012; 223: 45–55.

    Article  CAS  PubMed  Google Scholar 

  6. Song P, Zhao ZQ . The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001; 39: 281–286.

    Article  CAS  PubMed  Google Scholar 

  7. Hutchinson MR, Lewis SS, Coats BD, Skyba DA, Crysdale NY, Berkelhammer DL et al. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav Immun 2009; 23: 240–250.

    Article  CAS  PubMed  Google Scholar 

  8. Ledeboer A, Hutchinson MR, Watkins LR, Johnson KW . Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin Investig Drugs 2007; 16: 935–950.

    Article  CAS  PubMed  Google Scholar 

  9. Athos J, Impey S, Pineda VV, Chen X, Storm DR . Hippocampal CRE-mediated gene expression is required for contextual memory formation. Nat Neurosci 2002; 5: 1119–1120.

    Article  CAS  PubMed  Google Scholar 

  10. Alberini CM . Transcription factors in long-term memory and synaptic plasticity. Physiol Rev 2009; 89: 121–145.

    Article  CAS  PubMed  Google Scholar 

  11. Pulido-Salgado M, Vidal-Taboada JM, Saura J . C/EBPbeta and C/EBPdelta transcription factors: Basic biology and roles in the CNS. Prog Neurobiol 2015; 132: 1–33.

    Article  CAS  PubMed  Google Scholar 

  12. Cao JL, Vialou VF, Lobo MK, Robison AJ, Neve RL, Cooper DC et al. Essential role of the cAMP-cAMP response-element binding protein pathway in opiate-induced homeostatic adaptations of locus coeruleus neurons. Proc Natl Acad Sci USA 2010; 107: 17011–17016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Anderson EM, Reeves T, Kapernaros K, Neubert JK, Caudle RM . Phosphorylation of the N-methyl-d-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal. J Pharmacol Exp Ther 2015; 355: 496–505.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Inoue M, Mishina M, Ueda H . Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J Neurosci 2003; 23: 6529–6536.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hao S, Liu S, Zheng X, Zheng W, Ouyang H, Mata M et al. The role of TNFalpha in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats. Neuropsychopharmacology 2011; 36: 664–676.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang JW, Klemm DJ, Vinson C, Lane MD . Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis. J Biol Chem 2004; 279: 4471–4478.

    Article  CAS  PubMed  Google Scholar 

  17. Mijatovic T, Kruys V, Caput D, Defrance P, Huez G . Interleukin-4 and -13 inhibit tumor necrosis factor-alpha mRNA translational activation in lipopolysaccharide-induced mouse macrophages. J Biol Chem 1997; 272: 14394–14398.

    Article  CAS  PubMed  Google Scholar 

  18. te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG . Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 1990; 76: 1392–1397.

    CAS  PubMed  Google Scholar 

  19. Gautam S, Tebo JM, Hamilton TA . IL-4 suppresses cytokine gene expression induced by IFN-gamma and/or IL-2 in murine peritoneal macrophages. J Immunol 1992; 148: 1725–1730.

    CAS  PubMed  Google Scholar 

  20. Fink DJ, DeLuca NA, Goins WF, Glorioso JC . Gene transfer to neurons using herpes simplex virus-based vectors. Annu Rev Neurosci 1996; 19: 265–287.

    Article  CAS  PubMed  Google Scholar 

  21. Wojdasiewicz P, Poniatowski LA, Szukiewicz D . The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat Inflamm 2014; 2014: 561459.

    Article  Google Scholar 

  22. Guedon JM, Wu S, Zheng X, Churchill CC, Glorioso JC, Liu CH et al. Current gene therapy using viral vectors for chronic pain. Mol Pain 2015; 11: 27.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Hao S, Hu J, Fink DJ . Transgene-mediated enkephalin expression attenuates signs of naloxone-precipitated morphine withdrawal in rats with neuropathic pain. Behav Brain Res 2009; 197: 84–89.

    Article  CAS  PubMed  Google Scholar 

  24. Valverde O, Noble F, Beslot F, Dauge V, Fournie-Zaluski MC, Roques BP . Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur J Neurosci 2001; 13: 1816–1824.

    Article  CAS  PubMed  Google Scholar 

  25. Punch LJ, Self DW, Nestler EJ, Taylor JR . Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci 1997; 17: 8520–8527.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gellert VF, Holtzman SG . Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther 1978; 205: 536–546.

    CAS  PubMed  Google Scholar 

  27. Koob GF, Le Moal M . Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278: 52–58.

    Article  CAS  PubMed  Google Scholar 

  28. Laschka E, Teschemacher H, Mehraein P, Herz A . Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas. Psychopharmacologia 1976; 46: 141–147.

    Article  CAS  PubMed  Google Scholar 

  29. Maldonado R, Stinus L, Gold LH, Koob GF . Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 1992; 261: 669–677.

    CAS  PubMed  Google Scholar 

  30. Bozarth MA . Physical dependence produced by central morphine infusions: an anatomical mapping study. Neurosci Biobehav Rev 1994; 18: 373–383.

    Article  CAS  PubMed  Google Scholar 

  31. Harris GC, Aston-Jones G . Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 1994; 371: 155–157.

    Article  CAS  PubMed  Google Scholar 

  32. Stinus L, Le Moal M, Koob GF . Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 1990; 37: 767–773.

    Article  CAS  PubMed  Google Scholar 

  33. Williams JT, Christie MJ, Manzoni O . Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 2001; 81: 299–343.

    Article  CAS  PubMed  Google Scholar 

  34. Hwang I, Yang J, Hong S, Ju Lee E, Lee SH, Fernandes-Alnemri T et al. Non-transcriptional regulation of NLRP3 inflammasome signaling by IL-4. Immunol Cell Biol 2015; 93: 591–599.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Liu L, Coller JK, Watkins LR, Somogyi AA, Hutchinson MR . Naloxone-precipitated morphine withdrawal behavior and brain IL-1beta expression: Comparison of different mouse strains. Brain Behav Immun 2011; 25: 1223–1232.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Dunbar SA, Karamian I, Roberts L, Zhang J . Increased prostaglandin E2 release and activated Akt/beta-catenin signaling pathway occur after opioid withdrawal in rat spinal cord. Anesthesiology 2006; 105: 154–159.

    Article  CAS  PubMed  Google Scholar 

  37. Hao S, Mata M, Glorioso JC, Fink DJ . HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain 2006; 2: 6.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Finkel T . Signal transduction by reactive oxygen species. J Cell Biol 2011; 194: 7–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Dwivedi G, Gran MA, Bagchi P, Kemp ML . Dynamic redox regulation of IL-4 signaling. PLoS Comput Biol 2015; 11: e1004582.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Lee YW, Lee WH, Kim PH . Oxidative mechanisms of IL-4-induced IL-6 expression in vascular endothelium. Cytokine 2010; 49: 73–79.

    Article  CAS  PubMed  Google Scholar 

  41. Park KW, Baik HH, Jin BK . Interleukin-4-induced oxidative stress via microglial NADPH oxidase contributes to the death of hippocampal neurons in vivo. Curr Aging Sci 2008; 1: 192–201.

    Article  CAS  PubMed  Google Scholar 

  42. Sica A, Mantovani A . Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012; 122: 787–795.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Mosser DM, Edwards JP . Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958–969.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Zhang MZ, Wang X, Wang Y, Niu A, Wang S, Zou C et al. IL-4/IL-13-mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury. Kidney Int 2016; 91: 375–386.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Murray PJ, Wynn TA . Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11: 723–737.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Chawla JM, Pal H, Lal R, Jain R, Schooler N, Balhara YP . Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects. J Opioid Manag 2013; 9: 35–41.

    Article  PubMed  Google Scholar 

  47. Tompkins DA, Smith MT, Mintzer MZ, Campbell CM, Strain EC . A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine. J Pharmacol Exp Ther 2014; 348: 217–226.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Maldonado R . Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 1997; 21: 91–104.

    Article  CAS  PubMed  Google Scholar 

  49. Raghavendra V, Rutkowski MD, DeLeo JA . The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 2002; 22: 9980–9989.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J et al. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 2004; 24: 7353–7365.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Sun J, Liu S, Mata M, Fink DJ, Hao S . Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats. Gene Therapy 2012; 19: 101–108.

    Article  CAS  PubMed  Google Scholar 

  52. Ouyang H, Liu S, Zeng W, Levitt RC, Candiotti KA, Hao S . An emerging new paradigm in opioid withdrawal: a critical role for glia-neuron signaling in the periaqueductal gray. Sci World J 2012; 2012: 940613.

    Google Scholar 

  53. Lewis S, Hutchinson M, Coats B, Brzeski A, Maier S, Watkins L et al. AV411, a blood brain barrier permeable glial activation inhibitor, reduces morphine withdrawal behaviors in rats. Proc Soc Neurosci 2006; 765: 2.

    Google Scholar 

  54. Maier B, Lehnert M, Laurer HL, Mautes AE, Steudel WI, Marzi I . Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury. Shock 2006; 26: 122–127.

    Article  CAS  PubMed  Google Scholar 

  55. Zhang Q, Liu Q, Li T, Liu Y, Wang L, Zhang Z et al. Expression and colocalization of NMDA receptor and FosB/DeltaFosB in sensitive brain regions in rats after chronic morphine exposure. Neurosci Lett 2016; 614: 70–76.

    Article  CAS  PubMed  Google Scholar 

  56. Peregud DI, Yakovlev AA, Stepanichev MY, Onufriev MV, Panchenko LF, Gulyaeva NV . Content of mRNA for NMDA glutamate receptor subunits in the frontal cortex and striatum of rats after morphine withdrawal is related to the degree of abstinence. Bull Exp Biol Med 2012; 153: 835–838.

    Article  CAS  PubMed  Google Scholar 

  57. Wei J, Dong M, Xiao C, Jiang F, Castellino FJ, Prorok M et al. Conantokins and variants derived from cone snail venom inhibit naloxone-induced withdrawal jumping in morphine-dependent mice. Neurosci Lett 2006; 405: 137–141.

    Article  CAS  PubMed  Google Scholar 

  58. Johansson T, Elfverson M, Zhou Q, Nyberg F . Allosteric modulation of the NMDA receptor by neurosteroids in rat brain and the impact of long term morphine administration. Biochem Biophys Res Commun 2010; 401: 504–508.

    Article  CAS  PubMed  Google Scholar 

  59. Huber R, Pietsch D, Panterodt T, Brand K . Regulation of C/EBPbeta and resulting functions in cells of the monocytic lineage. Cell Signal 2012; 24: 1287–1296.

    Article  CAS  PubMed  Google Scholar 

  60. Marshall J, Dolan BM, Garcia EP, Sathe S, Tang X, Mao Z et al. Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPbeta levels to control neuronal survival. Neuron 2003; 39: 625–639.

    Article  CAS  PubMed  Google Scholar 

  61. Zhang RX, Li A, Liu B, Wang L, Ren K, Zhang H et al. IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 2008; 135: 232–239.

    Article  CAS  PubMed  Google Scholar 

  62. Nakagawa T, Satoh M . Involvement of glial glutamate transporters in morphine dependence. Ann N Y Acad Sci 2004; 1025: 383–388.

    Article  CAS  PubMed  Google Scholar 

  63. Broberg EK, Salmi AA, Hukkanen V . IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitis. Neurosci Lett 2004; 364: 173–178.

    Article  CAS  PubMed  Google Scholar 

  64. Poliani PL, Brok H, Furlan R, Ruffini F, Bergami A, Desina G et al. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. Hum Gene Ther 2001; 12: 905–920.

    Article  CAS  PubMed  Google Scholar 

  65. Furlan R, Poliani PL, Marconi PC, Bergami A, Ruffini F, Adorini L et al. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice. Gene Therapy 2001; 8: 13–19.

    Article  CAS  PubMed  Google Scholar 

  66. Oguchi T, Funahashi Y, Yokoyama H, Nishizawa O, Goins WF, Goss JR et al. Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception. Gene Therapy 2013; 20: 194–200.

    Article  CAS  PubMed  Google Scholar 

  67. Meye FJ, van Zessen R, Smidt MP, Adan RA, Ramakers GM . Morphine withdrawal enhances constitutive mu-opioid receptor activity in the ventral tegmental area. J Neurosci 2012; 32: 16120–16128.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Liu SB, Ma L, Guo HJ, Feng B, Guo YY, Li XQ et al. Gentiopicroside attenuates morphine rewarding effect through downregulation of GluN2B receptors in nucleus accumbens. CNS Neurosci Ther 2012; 18: 652–658.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Kuklin NA, Daheshia M, Marconi PC, Krisky DM, Rouse RJ, Glorioso JC et al. Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines. Virology 1998; 240: 245–253.

    Article  CAS  PubMed  Google Scholar 

  70. Gage PJ, Sauer B, Levine M, Glorioso JC . A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. J Virol 1992; 66: 5509–5515.

    CAS  PubMed  PubMed Central  Google Scholar 

  71. DeLuca NA, McCarthy AM, Schaffer PA . Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985; 56: 558–570.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Shepard AA, DeLuca NA . A second-site revertant of a defective herpes simplex virus ICP4 protein with restored regulatory activities and impaired DNA-binding properties. J Virol 1991; 65: 787–795.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Trang T, Sutak M, Quirion R, Jhamandas K . Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal. Br J Pharmacol 2003; 140: 295–304.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007; 27: 6006–6018.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Hao S, Mata M, Wolfe D, Huang S, Glorioso JC, Fink DJ . HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain. Mol Ther 2003; 8: 367–375.

    Article  CAS  PubMed  Google Scholar 

  76. Iida T, Yi H, Liu S, Huang W, Kanda H, Lubarsky DA et al. Spinal CPEB-mtROS-CBP signaling pathway contributes to perineural HIV gp120 with ddC-related neuropathic pain in rats. Exp Neurol 2016; 281: 17–27.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was partially supported by grants from the NIH DA020078 (SH), DA026734 (SH), DA025527 (SH), NS066792 (SH), DA34749 (SH) and NS038850 (David Fink, Neurology, University of Michigan, MI, USA). We acknowledge the assistance of Vikram Thakur Singh (Neurology, University of Michigan, MI, USA) in vector propagation. We thank the support from the Department of Anesthesiology, University of Miami, FL, USA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Hao.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yi, H., Iida, T., Liu, S. et al. IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats. Gene Ther 24, 224–233 (2017). https://doi.org/10.1038/gt.2017.11

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2017.11

This article is cited by

Search

Quick links